相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
Rita Nanda et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?
Daniel Sanghoon Shin et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
Kevin C. Soares et al.
JOURNAL OF IMMUNOTHERAPY (2014)
PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen-Specific CD8+ T Cells Induced by Melanoma Vaccines
Julien Fourcade et al.
CANCER RESEARCH (2014)
Accumulation of Memory Precursor CD8 T Cells in Regressing Tumors following Combination Therapy with Vaccine and Anti-PD-1 Antibody
Lavakumar Karyampudi et al.
CANCER RESEARCH (2014)
Molecular Pathways: HER3 Targeted Therapy
Kinisha Gala et al.
CLINICAL CANCER RESEARCH (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
The ErbB/HER family of protein-tyrosine kinases and cancer
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2014)
HER3, serious partner in crime Therapeutic approaches and potential biomarkers for effect of HER3-targeting
Arjan Kol et al.
PHARMACOLOGY & THERAPEUTICS (2014)
HER3 status by immunohistochemistry is correlated with poor prognosis in hormone receptor-negative breast cancer patients
Soo Youn Bae et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Antigen-Specific Bacterial Vaccine Combined with Anti-PD-L1 Rescues Dysfunctional Endogenous T Cells to Reject Long-Established Cancer
David C. Binder et al.
CANCER IMMUNOLOGY RESEARCH (2013)
An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+breast cancer models
Wenle Xia et al.
BREAST CANCER RESEARCH (2013)
Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells
Xiu-Rong Ren et al.
BREAST CANCER RESEARCH (2012)
Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome
Maria D. Begnami et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma
Mikiko Takikita et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
HER-3 Overexpression Is Prognostic of Reduced Breast Cancer Survival A Study of 4046 Patients
Connie G. Chiu et al.
ANNALS OF SURGERY (2010)
Targeting erbB receptors
Zheng Cai et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant
Thomas Frogne et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Quantitative Multiplexed Analysis of ErbB Family Coexpression for Primary Breast Cancer Prognosis in a Large Retrospective Cohort
Jennifer M. Giltnane et al.
CANCER (2009)
Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941
Teemu T. Junttila et al.
CANCER CELL (2009)
Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity
T. Osada et al.
CANCER GENE THERAPY (2009)
Anti-Programmed Death-1 Synergizes with Granulocyte Macrophage Colony-Stimulating Factor-Secreting Tumor Cell Immunotherapy Providing Therapeutic Benefit to Mice with Established Tumors
Betty Li et al.
CLINICAL CANCER RESEARCH (2009)
Biological determinants of endocrine resistance in breast cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2009)
HER3 is a determinant for poor prognosis in melanoma
Markus Reschke et al.
CLINICAL CANCER RESEARCH (2008)
High Expression of HER3 Is Associated with a Decreased Survival in Gastric Cancer
Mikiko Hayashi et al.
CLINICAL CANCER RESEARCH (2008)
Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: Molecular mechanism and clinical implications for endocrine therapy resistance
Grazia Arpino et al.
ENDOCRINE REVIEWS (2008)
Differential binding patterns of monoclonal antibody 2C4 to the ErbB3-p185her2/neu and the EGFR-p185her2/neu complexes
Z. Cai et al.
ONCOGENE (2008)
Induction of ErbB-3 Expression by α6β4 Integrin Contributes to Tamoxifen Resistance in ERβ1-Negative Breast Carcinomas (Publication with Expression of Concern. See vol. 17, 2022)
Valentina Folgiero et al.
PLOS ONE (2008)
Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs
Raymond M. Wong et al.
INTERNATIONAL IMMUNOLOGY (2007)
Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathway
Kazuko Sakai et al.
CANCER SCIENCE (2007)
Targeting HER proteins in cancer therapy and the role of the non-target HER3
A. C. Hsieh et al.
BRITISH JOURNAL OF CANCER (2007)
Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells
Bolin Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3
Natalia V. Sergina et al.
NATURE (2007)
Antiestrogen-resistant human breast cancer cells require activated Protein Kinase B/Akt for growth
T Frogne et al.
ENDOCRINE-RELATED CANCER (2005)
Can molecular markers predict when to implement treatment with aromatase inhibitors in invasive breast cancer?
S Tovey et al.
CLINICAL CANCER RESEARCH (2005)
Assessment of Her-1, Her-2, and Her-3 expression and Her-2 amplification in advanced stage ovarian carcinoma
CH Lee et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2005)
Generalized additive models for location, scale and shape
RA Rigby et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS (2005)
Worm plot: a simple diagnostic device for modelling growth reference curves
S van Buuren et al.
STATISTICS IN MEDICINE (2001)
Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses
CC Stamper et al.
NATURE (2001)
分享论文
